CVS Market Analysis

Wall Street coverage

third-party context

Wall Street coverage

$116.28median target· current $91.68 (+26.8%)27 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

News & Sentiment

26 articles · sorted by date
Page 1 of 2 · 26 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio24.92Forward 11.17
EPS (TTM)$3.68188.8% YoY
Profit margin1.2%HEALTHCARE
Market cap$117.31BLarge cap

Valuation

Forward P/E
11.17
PEG ratio
0.22
P/B
1.52
P/S (TTM)
0.28
EV/EBITDA
13.66

Profitability & growth

ROE (TTM)
6.2%
Operating margin
3.9%
Revenue growth YoY
7.1%
Dividend yield
2.8%
Beta
0.58
Last earnings
Aug 5, 2026 · Estimate $1.87 · Reported $2.58
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About CVS Health Corp

Company profile

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
ONE CVS DRIVE, WOONSOCKET, RI
Fiscal year end
December
Latest quarter
Jun 30, 2026
Market cap$117.31B
Shares outstanding$1.28B
52W high$110.00
52W low$68.48

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer